Lessons learned from mouse models of hemolytic transfusion reactions

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current opinion in hematology

• Publication date

  2008-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/MOH.0b013e328311f40aPMID 18832931PMCID PMC2646405
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reactions

  2022cited by this paper
• Cross‐linking induces non‐haemolytic antigen‐loss from transfused red blood cells: a potential role for rheumatoid factor

  2008cited by this paper
• Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions.

  2008cited by this paper
• Mouse models of IgG- and IgM-mediated hemolysis.

  2007cited by this paper
• Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene.

  2007cited by this paper
• Identification of a complement receptor 1 peptide for inhibition of immune hemolysis.

  2007cited by this paper
• Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes.

  2007cited by this paper
• Evaluation of liposomal clodronate in experimental spontaneous autoimmune hemolytic anemia in dogs.

  2006cited by this paper
• Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.

  2006cited by this paper
• Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies

  2006cited by this paper
• The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb‐expressing mice

  2006cited by this paper
• Nonhemolytic antibody-induced loss of erythrocyte surface antigen.

  2005cited by this paper
• Prevention of complement-mediated immune hemolysis by a small molecule compound.

  2004cited by this paper
• Glycophorin A requirement for expression of O‐linked antigens on the erythrocyte membrane

  2003cited by this paper
• Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model.

  2003cited by this paper
• Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy.

  2003cited by this paper
• Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice.

  2002cited by this paper
• Functional in vivo characterization of human monoclonal anti-D in NOD-scid mice.

  2002cited by this paper
• T‐cell specificity in murine autoimmune haemolytic anaemia induced by rat red blood cells

  2002cited by this paper
• An animal model for delayed hemolytic transfusion reactions.

  2001cited by this paper
• Deletion of the Murine Duffy Gene (Dfy) Reveals that the Duffy Receptor Is Functionally Redundant

  2000cited by this paper
• FUCOSYL TRANSFERASE (H) TRANSGENIC HEART TRANSPLANTS TO GAL-/- MICE

  2000cited by this paper
• Trends in the incidence of delayed hemolytic and delayed serologic transfusion reactions

  1999cited by this paper
• Generation of alpha 1,3galactosyltransferase deficient mice.

  1999cited by this paper
• Transgenic expression of human alpha1,2-fucosyltransferase (H-transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection.

  1998cited by this paper
• Adult and neonatal anti‐Gal response in knock‐out mice for α1,3galactosyltransferase

  1998cited by this paper
• Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells

  1997cited by this paper
• Down-regulation of Gal alpha(1,3)Gal expression by alpha1,2-fucosyltransferase: further characterization of alpha1,2-fucosyltransferase transgenic mice.

  1997cited by this paper
• Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase.

  1996cited by this paper
• Diverse antigen specificity of erythrocyte‐reactive monoclonal autoantibodies from NZB mice

  1996cited by this paper
• alpha 1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies.

  1996cited by this paper
• alpha 1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies.

  1996cited by this paper
• Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis

  1995cited by this paper
• Acute hemolytic transfusion reaction, a paradigm of the systemic inflammatory response: new insights into pathophysiology and treatment

  1995cited by this paper
• Molecular mechanisms resulting in pathogenic anti‐mouse erythrocyte antibodies in New Zealand black mice

  1993cited by this paper
• Hemolytic anemia in non‐obese diabetic mice

  1991cited by this paper
• Experimental model of autoimmune hemolytic anemia induced in mice with levodopa.

  1989cited by this paper
• Prp (proline-rich protein) genes linked to markers Es-12 (esterase-12), Ea-10 (erythrocyte alloantigen), and loci on distal mouse chromosome 6.

  1989cited by this paper
• Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.

  1988cited by this paper
• Post-transfusion crises in sickle cell anemia.

  1987cited by this paper
• Posttransfusion Crises in Sickle Cell Anemia: Role of Delayed Hemolytic Reactions to Transfusion

  1985cited by this paper
• Blood transfusion reactions in the cat.

  1982cited by this paper
• Delayed hemolytic transfusion reaction presenting as sickle-cell crisis.

  1980cited by this paper
• The murine H-2.7 specificity is an antigenic determinant of C4d, a fragment of the fourth component of the complement system

  1980cited by this paper
• Genetic Control of the Immune Response to the Ea-2 Alloantigen System of the Mouse

  1976cited by this paper
• Complement-independent clearance of IgG-sensitized erythrocytes: inhibition by cortisone.

  1974cited by this paper
• Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.

  1972cited by this paper
• Experimental Transfusion Reactions in Monkeys: Haemolytic, Coagulant and Renal Effects of Transfused Isoimmune IgG and IgM

  1972cited by this paper
• Biologic properties of 19 S and 7 S mouse isoantibodies directed against isoantigens of the H-2 system.

  1966cited by this paper
• PARTIAL IMMUNE ELIMINATION OF HOMOLOGOUS RED BLOOD CELLS IN MICE

  1964cited by this paper
• H‐5.A AND H‐6.A, TWO MOUSE ISOANTIGENS ON RED CELLS AND TISSUES DETECTED SEROLOGICALLY1

  1963cited by this paper
• Pathologic study of intravascular coagulation following incompatible blood transfusion in dogs. II. Intra-aortic injection of incompatible blood.

  1956cited by this paper
• Pathologic study of intravascular coagulation following incompatible blood transfusion in dogs. I. Intravenous injection of incompatible blood.

  1956cited by this paper

• CD47 regulates antigen modulation and red blood cell clearance following an incompatible transfusion

  2025cites this paper
• Dynamics of antibody engagement of red blood cells in vivo and in vitro

  2024cites this paper
• ABO blood groups and galectins: Implications in transfusion medicine and innate immunity.

  2024cites this paper
• The artificial oxygen carrier erythrocruorin—characteristics and potential significance in medicine

  2023cites this paper
• Cytosolic antigens prime RBC alloantibodies.

  2023cites this paper
• Complement activation during intravascular hemolysis: Implication for sickle cell disease and hemolytic transfusion reactions.

  2019cites this paper
• Mechanisms of complement activation under hemolytic conditions

  2017cites this paper
• Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia

  2017cites this paper
• Production of scFvs as anti-ABO antibodies antagonist for prevention of hemolytic transfusion reactions resulting ABO blood groups incompatibility between donor and recipient

  2016cites this paper
• Evidence of hemolysis in pigs infected with highly virulent African swine fever virus

  2016cites this paper
• Generation of mice expressing human RHAG and RHD blood group genes

  2015cites this paper
• Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies

  2014cites this paper
• Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models

  2014cites this paper
• Complications of Transfusion

  2014cites this paper
• Insights into the manipulation of the immune response to carbohydrate antigens with blood group functional-spacer-lipid constructs

  2012influential citation
• Modeling transfusion reactions with kodecytes and enabling ABO‐incompatible transfusion with function‐spacer‐lipid constructs

  2012cites this paper
• In vivo neutralization of anti‐A and successful transfusion of A antigen–incompatible red blood cells in an animal model

  2011cites this paper
• Modeling transfusion reactions and predicting in vivo cell survival with kodecytes

  2011cites this paper
• Translational research: an important integrated paradigm for transfusion medicine

  2009cites this paper